Debut Plus

₹3,360.7

▼ -92.19 -2.67%

17 Jul 2026

NSE Listed

Ajanta Pharma Limited (AJANTPHARM)

Volume: 1,12,113Avg Vol 1W: 88,601.2Avg Vol 1M: 1,26,719.8552W Range:₹2,329.9₹3,506.9
NSE BSE www.ajantapharma.com
Key Ratios
Checked 4h ago
Market Cap₹43,138 Cr
Current Price₹3,360.7
Previous Close₹3,452.89
High / Low (52w)₹3,506.9 / ₹2,329.9
Volume1,12,113
Avg Vol (1W)88,601.2
Avg Vol (1M)1,26,719.85
Stock P/E161.72
Book Value₹362.35
Dividend Yield81%
ROE23.33%
ROA17.16%
Revenue (TTM)₹4,743 Cr
Revenue Growth10.4%
Profit Margin19.37%
Total Debt₹0 Cr
Shares Outstanding12 Cr
Face Value₹2
EPS (TTM)₹90.33
P/B9.52
Debt / Equity0.04
50 DMA₹3,183.2
200 DMA₹2,851.98
Day change-2.67%
Price Chart
₹3,360.7▲ 20.61% · 1Y
₹3454₹238810.1L
2025-07-17
2026-07-16

20-day avg volume: 1.3L shares

Pros
  • Healthy return on equity of 23.3%.
  • Pays a dividend yield of 81.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 162.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,145 Cr₹1,187 Cr₹1,146 Cr₹1,170 Cr₹1,303 Cr₹1,354 Cr₹1,375 Cr₹1,422 Cr
EBITDA₹323 Cr₹296 Cr₹315 Cr₹275 Cr₹336 Cr₹344 Cr₹364 Cr₹349 Cr
Net Profit₹246 Cr₹216 Cr₹233 Cr₹225 Cr₹255 Cr₹260 Cr₹274 Cr₹267 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹2,076 Cr₹2,680 Cr₹2,916 Cr₹3,457 Cr₹3,841 Cr₹4,293 Cr₹4,743 Cr₹5,625 Cr
EBITDA₹515 Cr₹680 Cr₹908 Cr₹920 Cr₹751 Cr₹1,121 Cr₹1,210 Cr₹1,394 Cr
Net Profit₹387 Cr₹468 Cr₹654 Cr₹713 Cr₹588 Cr₹816 Cr₹920 Cr₹1,056 Cr
EPS43.9653.675.0954.9645.8964.7773.5384.51
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹2,696 Cr₹3,319 Cr₹3,779 Cr₹4,056 Cr₹4,679 Cr₹4,638 Cr₹5,015 Cr₹6,155 Cr
Total Liabilities₹451 Cr₹720 Cr₹783 Cr₹791 Cr₹1,291 Cr₹1,071 Cr₹1,225 Cr₹1,628 Cr
Equity₹2,245 Cr₹2,599 Cr₹2,996 Cr₹3,264 Cr₹3,388 Cr₹3,567 Cr₹3,790 Cr₹4,527 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹493 Cr₹612 Cr₹807 Cr₹801 Cr₹943 Cr₹1,097 Cr₹1,480 Cr₹888 Cr
Investing₹-223 Cr₹-224 Cr₹-282 Cr₹-74 Cr₹-560 Cr₹65 Cr₹-377 Cr₹-429 Cr
Financing₹-147 Cr₹-129 Cr₹-318 Cr₹-460 Cr₹-108 Cr₹-1,051 Cr₹-733 Cr₹-168 Cr
Free Cash Flow₹150 Cr₹372 Cr₹635 Cr₹652 Cr₹769 Cr₹945 Cr₹1,162 Cr₹523 Cr
Shareholding
Promoter 66.25% Institutions 26.63% Public 7.12%
Efficiency & Working Capital
ROCE29.1%
Interest Coverage86.5
Dividend Payout—
Debtor Days124 d
Inventory Days63 d
Payable Days36 d
Cash Conversion Cycle150 d
Working Capital Days187 d
Shareholding Details

As of 2026-06-30

Promoter63.5%
FII7.7%
DII21.8%
Institutions29.5%
Public7%
Promoter Pledge22.5%
No. of Shareholders65,296
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters66.2%66.2%66.2%66.3%66.3%66.3%66.3%66.3%66.2%66.2%66.2%63.5%
FIIs10%9.1%8.5%8.4%9.1%9.3%8.9%8.9%8.5%8%8.3%7.7%
DIIs14.9%16%17.5%17.4%17.1%17%17.5%17.5%17.9%18.6%18.4%21.8%
Public8.9%8.7%7.8%8%7.5%7.5%7.4%7.4%7.3%7.2%7.1%7%
Promoter Pledge12.4%12.3%12.3%11.6%11.2%11.2%12.6%14.4%15.3%17.3%17.9%22.5%
No. of Shareholders56,27754,35155,48870,31664,31566,89670,82768,88267,78565,40967,95565,296
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Rajesh M Agrawal, Trustee Rajesh Agrawal TrustShareholding of Promoter and Promoter Group14.5%1.81 Cr
Yogesh M Agrawal, Trustee Yogesh Agrawal TrustShareholding of Promoter and Promoter Group14.5%1.81 Cr
Aayush M Agrawal, Trustee Aayush Agrawal TrustShareholding of Promoter and Promoter Group11.3%1.41 Cr
Ravi P Agrawal, Trustee Ravi Agrawal TrustShareholding of Promoter and Promoter Group10.2%1.28 Cr
Gabs Investments Pvt LtdShareholding of Promoter and Promoter Group10.1%1.26 Cr
Kotak Flexicap FundPublic Shareholding3.3%40,97,176
Uti-flexi Cap FundPublic Shareholding3.1%38,85,153
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap FundPublic Shareholding2.8%34,71,661
Ganga Exports Being Represented By Yogesh Agrawal, Rajesh Agrawal & Ravi AgrawalShareholding of Promoter and Promoter Group2.7%33,48,261
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Midcap FundPublic Shareholding2.2%27,57,169
Tata Aia Life Insurance Co Ltd-whole Life Mid Cap Equity Fund-ulif 009 04/01/07 Wle 110Public Shareholding1.9%23,78,854
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap FundPublic Shareholding1.5%18,22,776
Hdfc Large And Mid Cap FundPublic Shareholding1.1%14,19,167
Ravi P AgrawalShareholding of Promoter and Promoter Group0.2%2,85,000
Aayush M AgrawalShareholding of Promoter and Promoter Group0%30,000
Mannalal B. AgrawalShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust00%2026-06-30
Yogesh M Agrawal, Trustee Yogesh Agrawal Trust00%2026-06-30
Ravi P Agrawal, Trustee Ravi Agrawal Trust15,37,69612%2026-06-30
Aayush M Agrawal, Trustee Aayush Agrawal Trust1.35 Cr95.9%2026-06-30
Ganga Exports Being Represented By Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal00%2026-06-30
Ravi P Agrawal00%2026-06-30
Aayush M Agrawal30,000100%2026-06-30
Mannalal B. Agrawal00%2026-06-30
Gabs Investments Pvt Ltd27,70,00022%2026-06-30
Kotak Flexicap Fund00%2026-06-30
Uti-flexi Cap Fund00%2026-06-30
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund00%2026-06-30
Board of Directors
NameDesignationYear
Mannalal B AgrawalChairman & Non Executive Dir.2026
Madhusudan B AgrawalVice Chairman & Executive Dire2026
Yogesh AgrawalED / MD / Promoter2026
Rajesh M AgrawalED / WTD / Joint MD / Promoter2026
David RasquinhaIndependent Non Exe. Director2026
Rajesh Shashikant DalalIndependent Non Exe. Director2026
Medha JoshiIndependent Non Exe. Director2026
Simi ThaparIndependent Non Exe. Director2026
Gaurang ShahSenior Vice President & CS2026
Segments — Product
SegmentRevenueShare
Pharmaceutical Products₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹1,654 Cr34.5%
Emerging Market₹1,853 Cr38.6%
Africa Institution₹160 Cr3.3%
USA₹1,134 Cr23.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2302525
Corporate Actions
TypeDateValueRemark
dividend2025-11-10₹28 (1400%)Interim 1
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20261,38100653251,772
202637000037
202600065325390
Insider / Designated-Person Trades

30 recent disclosure(s)

A V JAYAKUMARDisposal · 2,500
JAGDISH DWARKADAS JOSHIDisposal · 725
A V JAYAKUMARDisposal · 2,500
JAGDISH DWARKADAS JOSHIDisposal · 725
RAVI P AGRAWAL TRUSTEE RAVI AGRAWAL TRUSTDisposal · 34,50,000
AAYUSH M AGRAWAL TRUSTEE AAYUSH AGRAWAL TRUSTPledge · 28,55,925
Substantial Acquisitions (SAST)

2 disclosure(s)

Market09/06/2026 · 34,50,000
Buy Back19/06/2024 · 6,09,277
Company Information
Incorporated1979
ChairmanMannalal B Agrawal
AuditorB S R & Co LLP
Investor Email[email protected]; investorgrievance@ajantapha
🌐 www.ajantapharma.com ↗

📍 Ajanta House, Charkop Kandivli (W), Mumbai, Maharashtra, 400067

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Authum Invest & Infra Ltd.Abhishek Integrations Ltd.Aimtron Electronics Ltd.Airan LimitedAiro Lam LimitedANI Integrated Serv Ltd.Ajax Engineering LimitedAjmera Realty & Inf I Ltd.Ajooni Biotech LimitedAkanksha Power N Infra LimitedAkash Infra-Projects Ltd.A.K.Capital Services Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search